Oracle Investment Management Inc Immutep LTD Transaction History

Oracle Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.11 - $2.89 $102,227 - $140,017	48,449 Added 9.38%	564,879 $1.32 Million
Q3 2023 Nov 14, 2023	SELL	$1.75 - $2.37 $661,431 - $895,767	-377,961 Reduced 42.26%	516,430 $981,000
Q2 2023 Aug 14, 2023	SELL	$1.54 - $2.62 $702,872 - $1.2 Million	-456,411 Reduced 33.79%	894,391 $1.89 Million
Q1 2023 May 15, 2023	SELL	$1.63 - $2.06 $149,182 - $188,537	-91,523 Reduced 6.35%	1,350,802 $2.27 Million
Q4 2022 Feb 14, 2023	SELL	$1.6 - $2.53 $184,000 - $290,950	-115,000 Reduced 7.38%	1,442,325 $2.52 Million
Q2 2022 Aug 15, 2022	BUY	$1.96 - $3.09 $1.14 Million - $1.8 Million	581,169 Added 59.54%	1,557,325 $3.16 Million
Q4 2021 Feb 14, 2022	SELL	$3.09 - $4.81 $73,677 - $114,689	-23,844 Reduced 2.38%	976,156 $3.2 Million
Q2 2021 Aug 16, 2021	BUY	$3.02 - $5.21 $3.02 Million - $5.21 Million	1,000,000 New	1,000,000 $3.87 Million

2.41M

526K

222K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.